Mr. Hamed Shahbazi reports

WELL HEALTH SUBSIDIARY WELLSTAR PROVIDES CORPORATE UPDATE REFLECTING IMPROVED GUIDANCE AND A STRONG ACQUISITION PIPELINE

Well Health Technologies Corp. has provided a corporate update highlighting continued momentum across its majority-owned subsidiary, Wellstar Technologies Corp. Wellstar is tracking ahead of internal expectations, supported by robust organic growth, a strong acquisition pipeline and accelerating adoption of its Nexus AI solution.

Wellstar continues to demonstrate strong growth and execution, fuelled by accelerating demand for its digital health solutions and steady progress across its platform. The business is tracking ahead of internal expectations and has updated its guidance for fiscal 2025 to over $74-million in revenue and $22-million in adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). Wellstar is also expected to end the year with total annual recurring revenue (ARR) of approximately $62-million and an exit ARR (annual recurring revenue) of approximately $80-million, supported by robust organic expansion, continued adoption of its AI-powered tools and inclusive of completing three acquisitions that are currently in signed LOI (letter of intent) stage.

Amir Javidan, chief executive officer of Wellstar, commented: "We've had an excellent first half to 2025 as both our organic and inorganic growth engines are levelling up and are poised to deliver an outstanding, breakout performance for Wellstar in 2025. At the beginning of the year, we set an ambitious goal of reaching $100-million in revenues on a run-rate basis in the next couple of years and based on the latest forecasts, we believe we may be approaching that goal a few quarters earlier than previously anticipated. Our current goal for year-end exit ARR for fiscal 2025 is $80-million which would represent a 50-per-cent increase over last year's exit ARR figure."

Darren Hoegler, chief financial officer of Wellstar, commented: "This upward revision reflects stronger-than-expected traction across Wellstar's core product suite as well as strong execution in the company's capital allocation program. We currently have three signed LOIs with targets that all deliver high-margin SaaS solutions and would be highly accretive to our business. I'm also pleased to report that the two acquisitions that were completed in Q4 2024 are both operating well and tracking in alignment with or ahead of our plan. Our objective is to ensure disciplined execution and that the company continues to be positioned as a category leader in Canadian digital health, delivering durable, capital-efficient growth with significant operating leverage over time."

Three LOIs executed as Wellstar executes on deep acquisition pipeline

Wellstar has executed three letters of intent (LOIs) for acquisitions that are expected to contribute approximately $15-million in ARR, $16-million in revenue and over $5-million in adjusted EBITDA on an annualized run-rate basis. These prospective additions reflect Wellstar's continued focus on disciplined, accretive growth through the acquisition of complementary digital health assets that strengthen its core platform and expand its national footprint.

The acquisitions are aligned with Wellstar's long-term strategy to build a technology-enabled health care infrastructure that is efficient, scalable and outcomes driven. Each target adds strategic value by extending Wellstar's clinician enablement capabilities. The integrated nature of Wellstar's platform enables smooth onboarding and operational alignment, allowing new assets to benefit from shared infrastructure and drive incremental impact across the broader business.

Wellstar continues to advance a deep and well-qualified acquisition pipeline, with additional opportunities under review.

Strong early traction for Nexus AI with clinicians nationwide

Since its launch on May 7, 2025, Nexus AI has seen strong adoption, with over 2,400 providers signed up across primary care clinics, hospitals and regional health authorities. Nexus AI's first feature, an ambient medical scribe for real-time clinical documentation, is already demonstrating meaningful value for providers by reducing administrative burden and cognitive load. AI medical scribe technology has been shown to save providers up to two hours per day in charting and documentation.

Nexus AI serves as the central platform for Wellstar's expanding suite of AI-powered capabilities, including disease detection, medical coding and billing automation, and clinical decision support. Its compatibility with Canada's leading EMRs positions it as a scalable infrastructure layer for modern, intelligent health care delivery.

Clinician engagement with Nexus AI is expected to contribute to Wellstar's recurring SaaS (software-as-a-service) revenue and margin profile as deployments scale. Just as importantly, the platform's ability to orchestrate complex clinical workflows in an intuitive and context-aware way supports broader system-level efficiency and provider satisfaction.

As a prequalified vendor of the Canada Health Infoway AI Scribe Program, eligible primary care clinicians across Canada will receive a fully financed licence for 12 months of Nexus AI. Wellstar recognizes this as a transformative opportunity to advance Canada's vision of connected care, where AI-enabled technologies reduce physician burnout, improve patient experience, and allow providers to focus more on engagement and less on documentation. By delivering accurate, secure documentation at the point of care, Nexus AI empowers providers to reclaim meaningful patient connections and supports a broader effort to integrate AI technologies that promote more connected, patient-centred care.

About Well Health Technologies Corp.

Well's mission is to tech-enable healthcare providers. The company does this by developing the best technologies, services and support available, which ensures health care providers are empowered to positively impact patient outcomes. Well's comprehensive health care and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Well's solutions enable more than 42,000 health care providers between the United States and Canada, and power the largest owned and operated health care ecosystem in Canada with more than 210 clinics supporting primary care, specialized care and diagnostic services. In the United States, Well's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care and mental health. Well is publicly traded on the Toronto Stock Exchange under the symbol WELL and on the OTC Exchange under the symbol WHTCF.

We seek Safe Harbor.